<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="pbi13194-fig-0004" orientation="portrait" position="float">
 <label>Figure 4</label>
 <caption>
  <p>Plant‐produced 
   <styled-content style="fixed-case" toggle="no">CHKV</styled-content>mabs reduce 
   <styled-content style="fixed-case" toggle="no">CHIKV</styled-content> viraemia in mice. Wild‐type C57
   <styled-content style="fixed-case" toggle="no">BL</styled-content>/6J mice (
   <italic>N</italic> = 6 per group) were subcutaneously infected with 1 × 10
   <sup>5</sup> 
   <styled-content style="fixed-case" toggle="no">PFU</styled-content>s of 
   <styled-content style="fixed-case" toggle="no">CHIKV</styled-content> and treated intraperitoneally with 50 μg of indicated 
   <styled-content style="fixed-case" toggle="no">CHKV</styled-content>mab or 
   <styled-content style="fixed-case" toggle="no">PBS</styled-content> (negative control) 12 h post‐infection. Viral load in blood at day 2 dpi is presented as a ratio of 
   <styled-content style="fixed-case" toggle="no">CHIKV</styled-content> E1 copy number per 1000 copy of cellular β‐actin. ** and * indicate 
   <italic>P</italic> values &lt;0.01 and &lt;0.05, respectively, of 
   <styled-content style="fixed-case" toggle="no">CHKV</styled-content>mab‐treated mice compared to that of 
   <styled-content style="fixed-case" toggle="no">PBS</styled-content>‐treated, which were determined by 
   <italic>t</italic>‐tests.
  </p>
 </caption>
 <graphic id="nlm-graphic-7" xlink:href="PBI-18-266-g004" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
